Welcome to our dedicated page for 4Front Ventures news (Ticker: FFNTF), a resource for investors and traders seeking the latest updates and insights on 4Front Ventures stock.
News about 4Front Ventures Corp. (FFNTF) centers on its role as a vertically integrated multi-state cannabis operator and on significant legal and financial developments affecting the company. 4Front reports operations in Illinois and Massachusetts and facilities in Washington, with activities spanning cultivation, production, wholesale, and retail through its Mission-branded dispensaries and other outlets.
Recent news has focused on governance changes, financial reporting delays, and formal restructuring processes. The company has issued updates on delayed audited annual financial statements and related disclosures, applications for a management cease trade order, and the subsequent failure-to-file cease trade order issued by the Ontario Securities Commission. These items are important for readers tracking regulatory compliance and trading restrictions on the company’s securities.
Coverage also includes 4Front’s announcements that all of its U.S. subsidiaries filed for voluntary receivership in aid of liquidation under Massachusetts law and that a court-appointed Receiver has been authorized to operate, manage, and pursue the sale of those subsidiaries and their assets. Additional news has described the company’s assignment into bankruptcy under the Canadian Bankruptcy and Insolvency Act and the appointment of a trustee in those proceedings.
Alongside these restructuring developments, earlier releases have highlighted operational updates such as the official ribbon cutting of a large cultivation and production facility in Matteson, Illinois, and commentary on wholesale and retail performance in Illinois, Massachusetts, and Washington. Readers following FFNTF news can use this page to review the sequence of corporate, regulatory, and operational announcements that shape the company’s current situation.
4Front Ventures reported Q4 2020 Systemwide Pro Forma Revenue of $25.0 million, up 12% quarter-over-quarter, and a full-year revenue of $88.1 million, marking a 203% increase from the previous year. Adjusted EBITDA was $5.9 million, reflecting a 59% sequential rise. The company reiterated its FY 2021 guidance of $170-180 million in revenue and $40-50 million in EBITDA. 4Front is focusing on expanding its cannabis operations in Illinois and California, aiming for long-term revenue potential of up to $650 million.
4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF) has announced participation in two upcoming cannabis conferences in April 2021. The company will engage in one-on-one meetings at the ROTH Virtual Golden Cannabis Day on April 7, and CEO Leo Gontmakher will present at the PI Financial Golden State Green on April 14. 4Front operates as a multi-state cannabis operator, boasting over 25 brands, with a focus on mass-produced, low-cost cannabis products. The company is headquartered in Phoenix and operates in multiple states including Illinois, Massachusetts, and California.
4Front Ventures Corp. (CSE: FFNT, OTCQX: FFNTF) will release its Fiscal Year 2020 earnings on April 6, 2021, post market close. The company will host a conference call at 5:00 p.m. ET that same day to discuss financial results and operational updates. 4Front operates as a multi-state cannabis operator, manufacturing a wide range of cannabis brands, distributed through retail and their Mission dispensaries. The company is headquartered in Phoenix, Arizona, and has operations across several states including Illinois, Massachusetts, and California.
4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) has announced the commencement of construction for a new Mission Dispensary in Calumet City, Illinois, which will cater to both adult-use and medical cannabis customers. The dispensary, located at 1330 Torrence Avenue, is expected to open by the end of the year. Additionally, President Kris Krane has been appointed to Illinois' Adult Use Cannabis Health Advisory Committee to help steer cannabis policy in the state. The company recently sold three Maryland dispensaries for approximately $5.5 million, focusing on strengthening its Illinois operations.
4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) has received authorization from the Massachusetts Cannabis Control Commission to commence adult-use retail and production operations at its Mission Dispensary in Worcester. The soft launch is set for September 4, with a grand opening on September 9, 2020. This entry into the adult-use market is expected to enhance 4Front's growth in Massachusetts and increase its total addressable market. Additionally, expansion plans at the Georgetown facility aim to boost output to meet demand.
4Front Ventures Corp. reported a 1.3% increase in Q2 2020 systemwide pro forma sales to $19M, despite a 10% revenue decline from the Chicago dispensary closure. Positive operating cash flow was achieved in August, with expectations for positive adjusted EBITDA starting in Q3 2020. The company anticipates strong revenue growth driven by recreational approvals in Massachusetts and expansion in Illinois. All expansion projects remain on track for Q4 completion, and divestitures of non-core assets are nearing finalization.
4Front Ventures Corp. (CSE: FFNT) (OTCQX: FFNTF) announced its fiscal second quarter 2020 earnings press release will be issued on August 31, 2020, after U.S. markets close. A conference call will follow on the same day at 5:00 p.m. EDT to discuss operational and financial results. The company, headquartered in Phoenix, Arizona, operates in multiple states, providing over 25 cannabis brands. With its focus on low-cost quality products, 4Front aims to strengthen its market presence.